Finally, CD44 has been demonstrated to interact with EGFR phosphorylation and activation in vitro in HNSCC cells, and it has been observed that a decrease in CD44 levels is associated with a reduction in p-EGFR and tumor growth.18 The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.